News from eusa pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 29, 2019, 04:00 ET EUSA Pharma Announces New QARZIBA®▼ (Dinutuximab beta) Data to Be Presented at 2019 ASCO Annual Meeting

EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announces that the Principal Investigators from...


May 15, 2019, 04:00 ET EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announced the strengthening of its senior...


Dec 05, 2018, 04:00 ET EUSA Pharma Appoints Jeffrey S. Hackman as President US Operations

- EUSA to Open New US Headquarters in Boston, MA - - Significant US Expansion to Complete EUSA's Transatlantic Commercial Platform - EUSA Pharma...


Jul 11, 2018, 04:00 ET EUSA Pharma Announces Sale of Critical Care Business to SERB Pharmaceuticals

- Completes EUSA's transition into oncology and rare disease-focused biopharmaceutical company - - Expands SERB's product portfolio for rare and...


Mar 07, 2018, 04:00 ET EUSA Pharma Appoints Industry Veteran Rolf K Hoffmann to its Board of Directors

EUSA Pharma (EUSA), a world-class specialty pharmaceutical company focused on oncology and oncology supportive care, today announced the appointment...


Jun 23, 2017, 07:58 ET EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for the First-Line Treatment of Advanced Renal Cell Carcinoma in Europe

EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced that the European...


May 10, 2017, 04:00 ET European Commission Approves EUSA Pharma’s Dinutuximab Beta for the Treatment of Patients with High-Risk Neuroblastoma

- Only anti-GD2 monoclonal antibody approved in the European Union - - Expedited approval based on data from multiple clinical trials conducted...


Mar 27, 2017, 05:01 ET Dinutuximab beta erhält positive Empfehlung für die Behandlung von Hochrisiko-Neuroblastom in Europa

EUSA Pharma gab heute bekannt, dass der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittel-Agentur ein positives Gutachten...


Mar 27, 2017, 04:00 ET Dinutuximab beta reçoit une recommandation positive pour le traitement du neuroblastome à haut risque en Europe

EUSA Pharma a annoncé aujourd'hui que le Comité des médicaments à usage humain (CHMP) de l'Agence européenne des médicaments a émis un avis favorable ...


Mar 27, 2017, 04:00 ET EUSA Pharma and Apeiron Biologics Receive Positive CHMP Opinion for dinutuximab beta for the Treatment of High-risk neuroblastoma in Europe

EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, and Apeiron Biologics today announced...


Mar 27, 2017, 04:00 ET El dinutuximab beta recibe una recomendación positiva para el tratamiento del neuroblastoma de alto riesgo en Europa

EUSA Pharma ha anunciado hoy que el Comité de Medicamentos para Uso Humano (CHMP) de la Agencia Europea de Medicamentos ha emitido un dictamen...


Oct 04, 2016, 04:00 ET EUSA Pharma Acquires Global Rights to Neuroblastoma Treatment Isqette® (Dinutuximab Beta) from Apeiron Biologics

EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced the acquisition of...


Apr 12, 2016, 04:00 ET EUSA Pharma Announces Acquisition of Global Rights to Next Generation Oncology Supportive Care Product Arcoral® Tab from Arcoral Pharma

EUSA Pharma (EUSA), a recently-established specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced...


Sep 09, 2015, 04:00 ET EUSA Pharma Appoints William W Crouse to its Board of Directors

EUSA Pharma (EUSA), a recently-established specialty pharmaceutical company with global reach, today announced the appointment of William W Crouse to ...


Apr 21, 2015, 04:00 ET EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors

EUSA Pharma (EUSA), a recently-established profitable specialty pharmaceutical company with global reach, today announced the appointment of Lee...


Mar 23, 2015, 05:00 ET EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals

EUSA Pharma (EUSA), a newly-established profitable specialty pharmaceutical business with global reach, today announced its official launch following ...


Feb 02, 2012, 04:30 ET EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC® for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that...


Nov 18, 2011, 08:58 ET EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE™ for Treatment of Acute Lymphoblastic Leukemia

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that...


Jan 05, 2011, 05:16 ET EUSA Pharma Announces Priority Review Status for ERWINAZE(R) BLA

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that...


Nov 09, 2010, 05:00 ET EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) for Treatment of Acute Lymphoblastic Leukemia

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that...


Nov 03, 2010, 07:46 ET EUSA Pharma Announces 10-Year Outcome Data Demonstrating Utility of PROSTASCINT(R) in Guiding Prostate Cancer Radiotherapy and Improving Disease-Free Survival

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the...


Sep 01, 2010, 04:59 ET EUSA Pharma Announces the Appointment of Stephen A. Stamp to its Board of Directors

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced the appointment of ...


Jul 06, 2010, 03:59 ET EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has...